Your search returned 8 results.

Sort
Results
1.
Guidelines for the indications for 131I remnant ablation on differentiated thyroid cancer: a distillation and comparison of guidelines from seven organizations MedStar authors:
  • Khorjekar, Gauri
  • Orquiza, Michael D
  • Van Nostrand, Douglas
Year: 2013
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Orquiza M, Guan H, Van Nostrand D, Li Y, Teng W, Khorjekar G
Local accession number:
  • 2013_7
2.
Evaluation of lithium as adjunctive treatment of 131I therapy for differentiated thyroid cancer: an educational exhibit MedStar authors:
  • Khorjekar, Gauri
  • Orquiza, Michael D
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
Year: 2013
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Orquiza M, Van Nostrand D, Khorjekar G, Elboga U, Guan H, Wartofsky L
Local accession number:
  • 2013_7
3.
Alpharadinr in the treatment of skeletal metastasis secondary to metastatic prostate cancer: an educational exhibit MedStar authors:
  • Duong, Eric
  • Khorjekar, Gauri
  • Orquiza, Michael D
  • Van Nostrand, Douglas
Year: 2013
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Orquiza M, Duong E, Khorjekar G, Van Nostrand D
Local accession number:
  • 2013_7
4.
Characterization of salivary gland side effects secondary to 131I therapy: final report of the thyroid cancer survivors' association, inc. (ThyCa) national survey for intermediate and long term results MedStar authors:
  • Hall, Jordan
  • Khorjekar, Gauri
  • Mete, Mihriye
  • Orquiza, Michael D
  • Van Nostrand, Douglas
Year: 2013
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Orquiza M, Hall J, Van Nostrand D, Khorjekar G, Brennan M, McIver B, Mete M, Bloom G
Local accession number:
  • 2013_7
5.
Correlation of 124I PET dosimetry with clinical response of 131I therapy (Tx) for Metastatic Differentiated Thyroid Cancer (DTC). MedStar authors:
  • Atkins, Frank
  • Garcia, Carlos
  • Khorjekar, Gauri
  • Mete, Mihriye
  • Orquiza, Michael D
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
Year: 2013
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Khorjekar G, Orquiza MD, Atkins F, Mete M, Garcia C, Wartofsky L, Van Nostrand D
Local accession number:
  • 2013_2
6.
Correlation of 124 I PET dosimetry with clinical response of 131 I therapy for metastatic differentiated thyroid cancer. MedStar authors:
  • Atkins, Frank
  • Garcia, Carlos
  • Khorjekar, Gauri
  • Mete, Mihriye
  • Orquiza, Michael D
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
Year: 2013
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Khorjekar G, Senthamizhchelvan S, Hobbs R, Orquiza M, Atkins F, Mete M, Garcia C, Wartofsky L, Sgouros G, Van Nostrand D
Local accession number:
  • 2013_16
7.
Correlation of 124I PET dosimetry with clinical response of 131I therapy (Tx) for metastatic differentiated thyroid cancer (DTC) MedStar authors:
  • Atkins, Frank
  • Garcia, Carlos
  • Khorjekar, Gauri
  • Mete, Mihriye
  • Orquiza, Michael D
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
Year: 2013
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
  • Washington Cancer Institute
Department:
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Khorjekar G, Senthamizhchelvan S, Hobbs R, Orquiza M, Atkins F, Mete M, Garcia C, Wartofsky L, Sgouros G, Van Nostrand D
Local accession number:
  • 2013_4
8.
Characterization of sialoadenitis (SA) after administration of continuous sialogogues (SGs) during the day and night after 131I therapy (tx) MedStar authors:
  • Acio, Elmo
  • Burman, Kenneth D
  • Garcia, Carlos
  • Khorjekar, Gauri
  • Kulkarni, Kanchan
  • Orquiza, Michael D
  • Schneider, Mark
  • Van Nostrand, Douglas
  • Wartofsky, Leonard
Year: 2013
Institution:
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
  • Medicine/Nuclear Medicine
Form of publication:
  • Conference
All authors:
  • Orquiza M, Khorjekar G, Schneider M, Kulkarni K, Garcia C, Acio E, Burman K, Wartofsky L, Van Nostrand D
Local accession number:
  • 2013_7
Pages

Powered by Koha